GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Gelesis Holdings Inc (OTCPK:GLSHQ) » Definitions » Piotroski F-Score

Gelesis Holdings (Gelesis Holdings) Piotroski F-Score : N/A (As of May. 05, 2024)


View and export this data going back to 2022. Start your Free Trial

What is Gelesis Holdings Piotroski F-Score?

The zones of discrimination were as such:

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Gelesis Holdings has an F-score of 3. It is a bad or low score, which usually implies poor business operation.

The historical rank and industry rank for Gelesis Holdings's Piotroski F-Score or its related term are showing as below:


Gelesis Holdings Piotroski F-Score Historical Data

The historical data trend for Gelesis Holdings's Piotroski F-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Gelesis Holdings Piotroski F-Score Chart

Gelesis Holdings Annual Data
Trend Dec21 Dec22
Piotroski F-Score
N/A N/A

Gelesis Holdings Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23
Piotroski F-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only N/A N/A N/A N/A N/A

Competitive Comparison of Gelesis Holdings's Piotroski F-Score

For the Biotechnology subindustry, Gelesis Holdings's Piotroski F-Score, along with its competitors' market caps and Piotroski F-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Gelesis Holdings's Piotroski F-Score Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Gelesis Holdings's Piotroski F-Score distribution charts can be found below:

* The bar in red indicates where Gelesis Holdings's Piotroski F-Score falls into.


How is the Piotroski F-Score calculated?

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Jun23) TTM:Last Year (Jun22) TTM:
Net Income was -14.229 + -24.51 + -5.246 + -7.681 = $-51.67 Mil.
Cash Flow from Operations was -21.681 + -16.275 + -8.696 + 0.617 = $-46.04 Mil.
Revenue was 6.652 + 2.628 + 1.753 + 1.107 = $12.14 Mil.
Gross Profit was 3.036 + -11.615 + 0.516 + 0.609 = $-7.45 Mil.
Average Total Assets from the begining of this year (Jun22)
to the end of this year (Jun23) was
(138.969 + 130.517 + 103.324 + 98.78 + 95.875) / 5 = $113.493 Mil.
Total Assets at the begining of this year (Jun22) was $138.97 Mil.
Long-Term Debt & Capital Lease Obligation was $27.96 Mil.
Total Current Assets was $24.68 Mil.
Total Current Liabilities was $50.24 Mil.
Net Income was -30.825 + -19.383 + -5.791 + -12.598 = $-68.60 Mil.

Revenue was 3.014 + 2.892 + 7.514 + 8.973 = $22.39 Mil.
Gross Profit was 0.251 + 0.493 + 2.601 + 4.187 = $7.53 Mil.
Average Total Assets from the begining of last year (Jun21)
to the end of last year (Jun22) was
(0 + 0 + 146.301 + 152.879 + 138.969) / 5 = $146.04966667 Mil.
Total Assets at the begining of last year (Jun21) was $0.00 Mil.
Long-Term Debt & Capital Lease Obligation was $31.24 Mil.
Total Current Assets was $61.65 Mil.
Total Current Liabilities was $36.71 Mil.

*Note: If the latest quarterly/semi-annual/annual total assets data is 0, then we will use previous quarterly/semi-annual/annual data for all the items in the balance sheet.

Profitability

Question 1. Return on Assets (ROA)

Net income before extraordinary items for the year divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Gelesis Holdings's current Net Income (TTM) was -51.67. ==> Negative ==> Score 0.

Question 2. Cash Flow Return on Assets (CFROA)

Net cash flow from operating activities (operating cash flow) divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Gelesis Holdings's current Cash Flow from Operations (TTM) was -46.04. ==> Negative ==> Score 0.

Question 3. Change in Return on Assets

Compare this year's return on assets (1) to last year's return on assets.

Score 1 if it's higher, 0 if it's lower.

ROA (This Year)=Net Income/Total Assets (Jun22)
=-51.666/138.969
=-0.37178076

ROA (Last Year)=Net Income/Total Assets (Jun21)
=-68.597/0
=

Gelesis Holdings's return on assets of this year was -0.37178076. Gelesis Holdings's return on assets of last year was . ==> This year is higher. ==> Score 1.

Question 4. Quality of Earnings (Accrual)

Compare Cash flow return on assets (2) to return on assets (1)

Score 1 if CFROA > ROA, 0 if CFROA <= ROA.

Gelesis Holdings's current Net Income (TTM) was -51.67. Gelesis Holdings's current Cash Flow from Operations (TTM) was -46.04. ==> -46.04 > -51.67 ==> CFROA > ROA ==> Score 1.

Funding

Question 5. Change in Gearing or Leverage

Compare this year's gearing (long-term debt divided by average total assets) to last year's gearing.

Score 0 if this year's gearing is higher, 1 otherwise.

Gearing (This Year: Jun23)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Jun22 to Jun23
=27.963/113.493
=0.24638524

Gearing (Last Year: Jun22)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Jun21 to Jun22
=31.237/146.04966667
=0.2138793

Gelesis Holdings's gearing of this year was 0.24638524. Gelesis Holdings's gearing of last year was 0.2138793. ==> Last year is lower than this year ==> Score 0.

Question 6. Change in Working Capital (Liquidity)

Compare this year's current ratio (current assets divided by current liabilities) to last year's current ratio.

Score 1 if this year's current ratio is higher, 0 if it's lower

Current Ratio (This Year: Jun23)=Total Current Assets/Total Current Liabilities
=24.678/50.241
=0.49119245

Current Ratio (Last Year: Jun22)=Total Current Assets/Total Current Liabilities
=61.651/36.707
=1.67954341

Gelesis Holdings's current ratio of this year was 0.49119245. Gelesis Holdings's current ratio of last year was 1.67954341. ==> Last year's current ratio is higher ==> Score 0.

Question 7. Change in Shares in Issue

Compare the number of shares in issue this year, to the number in issue last year.

Score 0 if there is larger number of shares in issue this year, 1 otherwise.

Gelesis Holdings's number of shares in issue this year was 73.335. Gelesis Holdings's number of shares in issue last year was 72.423. ==> There is larger number of shares in issue this year. ==> Score 0.

Efficiency

Question 8. Change in Gross Margin

Compare this year's gross margin (Gross Profit divided by sales) to last year's.

Score 1 if this year's gross margin is higher, 0 if it's lower.

Gross Margin (This Year: TTM)=Gross Profit/Revenue
=-7.454/12.14
=-0.61400329

Gross Margin (Last Year: TTM)=Gross Profit/Revenue
=7.532/22.393
=0.33635511

Gelesis Holdings's gross margin of this year was -0.61400329. Gelesis Holdings's gross margin of last year was 0.33635511. ==> Last year's gross margin is higher ==> Score 0.

Question 9. Change in asset turnover

Compare this year's asset turnover (total sales for the year divided by total assets at the beginning of the year) to last year's asset turnover ratio.

Score 1 if this year's asset turnover ratio is higher, 0 if it's lower

Asset Turnover (This Year)=Revenue/Total Assets at the Beginning of This Year (Jun22)
=12.14/138.969
=0.08735761

Asset Turnover (Last Year)=Revenue/Total Assets at the Beginning of Last Year (Jun21)
=22.393/0
=

Gelesis Holdings's asset turnover of this year was 0.08735761. Gelesis Holdings's asset turnover of last year was . ==> This year's asset turnover is higher. ==> Score 1.

Evaluation

Piotroski F-Score= Que. 1+ Que. 2+ Que. 3+Que. 4+Que. 5+Que. 6+Que. 7+Que. 8+Que. 9
=0+0+1+1+0+0+0+0+1
=3

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Gelesis Holdings has an F-score of 3. It is a bad or low score, which usually implies poor business operation.

Gelesis Holdings  (OTCPK:GLSHQ) Piotroski F-Score Explanation

The developer of the system is Joseph D. Piotroski is relatively unknown accounting professor who shuns publicity and rarely gives interviews.

He graduated from the University of Illinois with a B.S. in accounting in 1989, received an M.B.A. from Indiana University in 1994. Five years later, in 1999, after earning a Ph.D. in accounting from the University of Michigan, he became an associate professor of accounting at the University of Chicago.

In 2000, he wrote a research paper called "Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers" (pdf).

He wanted to see if he can develop a system (using a simple nine-point scoring system) that can increase the returns of a strategy of investing in low price to book (referred to in the paper as high book to market) value companies.

What he found was something that exceeded his most optimistic expectations.

Buying only those companies that scored highest (8 or 9) on his nine-point scale, or F-Score as he called it, over the 20 year period from 1976 to 1996 led to an average out-performance over the market of 13.4%.

Even more impressive were the results of a strategy of investing in the highest F-Score companies (8 or 9) and shorting companies with the lowest F-Score (0 or 1).

Over the same period from 1976 to 1996 (20 years) this strategy led to an average yearly return of 23%, substantially outperforming the average S&P 500 index return of 15.83% over the same period.


Gelesis Holdings Piotroski F-Score Related Terms

Thank you for viewing the detailed overview of Gelesis Holdings's Piotroski F-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


Gelesis Holdings (Gelesis Holdings) Business Description

Traded in Other Exchanges
N/A
Address
501 Boylston Street, Suite 6102, Boston, MA, USA, 02116
Gelesis Holdings Inc is a biotherapeutics company advancing a novel category of treatments for weight management and gut related chronic diseases. Its portfolio includes Plenity, an FDA-cleared product to aid in weight management, as well as potential therapies in development for patients with Type 2 Diabetes, Non-alcoholic Fatty Liver Disease (NAFLD)/Non-alcoholic Steatohepatitis (NASH), and Functional Constipation.
Executives
Raju S Kucherlapati director 77 LOUIS PASTEUR AVENUE, BOSTON MA 02115
Bomsmaster Llc 10 percent owner 195 CHURCH STREET, 15TH FLOOR, NEW HAVEN CT 06510
Paul R. Fonteyne director C/O RESTORBIO, INC., 501 BOYLSTON STREET SUITE 6102, BOSTON MA 02116
Hpso Spv Ltd 10 percent owner SARNIA HOUSE, LE TRUCHOT, ST PETER PORT Y7 GY1 4NA
Alessandro Sannino officer: Lead Project Scientist C/O GELESIS, INC., 501 BOYLSTON STREET, SUITE 6102, BOSTON MA 02116
Dominic Perks director GELESIS, INC., 501 BOYLSTON STREET, SUITE 1602, BOSTON NY 02116
David A. Pass officer: Chief Op. & Comm. Officer GELESIS, INC., 501 BOYLSTON STREET, SUITE 1602, BOSTON MA 02116
Elaine Chiquette officer: Chief Scientific Officer C/O GELESIS, INC., 501 BOYLSTON STREET, SUITE 6102, BOSTON MA 02116
Jane Wildman director C/O GELESIS, INC., 501 BOYLSTON STREET, SUITE 6102, BOSTON MA 02116
Harry L. Leider officer: Chief Medical Officer C/O GELESIS, INC., 501 BOYLSTON STREET, SUITE 6102, BOSTON MA 02116
Clayton Christopher director 2407 S. CONGRESS AVE, SUITE E103, AUSTIN TX 78704
Health Plc Puretech 10 percent owner 6 TIDE STREET, SUITE 400, BOSTON MA 02210
Ssd2, Llc 10 percent owner 142 TEMPLE STREET, SUITE 206, NEW HAVEN CT 06511
Yishai Zohar director, officer: President & CEO C/O GELESIS, INC., 501 BOYLSTON ST., SUITE 6102, BOSTON MA 02116
Elon Boms 10 percent owner C/O THIMBLE POINT ACQUISITION CORP., 195 CHURCH STREET, 15TH FLOOR, NEW HAVEN CT 06510

Gelesis Holdings (Gelesis Holdings) Headlines

From GuruFocus

Gelesis to Report First Quarter 2022 Financial Results on May 12, 2022

By Business Wire Business Wire 05-09-2022